Sigma-1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury
- PMID: 34658788
- PMCID: PMC8515188
- DOI: 10.3389/fncel.2021.685201
Sigma-1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury
Abstract
The sigma-1 receptor (Sig-1R) is a chaperone receptor that primarily resides at the mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) and acts as a dynamic pluripotent modulator regulating cellular pathophysiological processes. Multiple pharmacological studies have confirmed the beneficial effects of Sig-1R activation on cellular calcium homeostasis, excitotoxicity modulation, reactive oxygen species (ROS) clearance, and the structural and functional stability of the ER, mitochondria, and MAM. The Sig-1R is expressed broadly in cells of the central nervous system (CNS) and has been reported to be involved in various neurological disorders. Traumatic brain injury (TBI)-induced secondary injury involves complex and interrelated pathophysiological processes such as cellular apoptosis, glutamate excitotoxicity, inflammatory responses, endoplasmic reticulum stress, oxidative stress, and mitochondrial dysfunction. Thus, given the pluripotent modulation of the Sig-1R in diverse neurological disorders, we hypothesized that the Sig-1R may affect a series of pathophysiology after TBI. This review summarizes the current knowledge of the Sig-1R, its mechanistic role in various pathophysiological processes of multiple CNS diseases, and its potential therapeutic role in TBI.
Keywords: apoptosis; calcium homeostasis; endoplasmic reticulum stress; excitotoxicity; inflammatory responses; sigma-1 receptor; traumatic brain injury.
Copyright © 2021 Shi, Chen, Chen, Yang, Yue, Zhang and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![FIGURE 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8515188/bin/fncel-15-685201-g001.gif)
![FIGURE 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8515188/bin/fncel-15-685201-g002.gif)
![FIGURE 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8515188/bin/fncel-15-685201-g003.gif)
![FIGURE 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8515188/bin/fncel-15-685201-g004.gif)
Similar articles
-
Activation of Sigma-1 Receptor Alleviates ER-Associated Cell Death and Microglia Activation in Traumatically Injured Mice.J Clin Med. 2022 Apr 22;11(9):2348. doi: 10.3390/jcm11092348. J Clin Med. 2022. PMID: 35566476 Free PMC article.
-
Sigma receptor knockdown augments dysfunction and apoptosis of beta cells induced by palmitate.Exp Biol Med (Maywood). 2021 Jul;246(13):1491-1499. doi: 10.1177/1535370221997780. Epub 2021 Mar 9. Exp Biol Med (Maywood). 2021. PMID: 33715527 Free PMC article.
-
Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases.J Biomed Sci. 2017 Sep 16;24(1):74. doi: 10.1186/s12929-017-0380-6. J Biomed Sci. 2017. PMID: 28917260 Free PMC article. Review.
-
The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.Curr Neuropharmacol. 2018;16(1):97-116. doi: 10.2174/1570159X15666170529104323. Curr Neuropharmacol. 2018. PMID: 28554311 Free PMC article. Review.
-
The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.Trends Pharmacol Sci. 2016 Apr;37(4):262-278. doi: 10.1016/j.tips.2016.01.003. Epub 2016 Feb 9. Trends Pharmacol Sci. 2016. PMID: 26869505 Free PMC article. Review.
Cited by
-
Cytosolic Escape of Mitochondrial DNA Triggers cGAS-STING Pathway-Dependent Neuronal PANoptosis in Response to Intermittent Hypoxia.Neurochem Res. 2024 Aug;49(8):2228-2248. doi: 10.1007/s11064-024-04151-7. Epub 2024 Jun 4. Neurochem Res. 2024. PMID: 38833090
-
Endoplasmic reticulum stress and the unfolded protein response: emerging regulators in progression of traumatic brain injury.Cell Death Dis. 2024 Feb 20;15(2):156. doi: 10.1038/s41419-024-06515-x. Cell Death Dis. 2024. PMID: 38378666 Free PMC article. Review.
-
Targeting CaN/NFAT in Alzheimer's brain degeneration.Front Immunol. 2023 Nov 23;14:1281882. doi: 10.3389/fimmu.2023.1281882. eCollection 2023. Front Immunol. 2023. PMID: 38077352 Free PMC article. Review.
-
Sestrin2 can alleviate endoplasmic reticulum stress to improve traumatic brain injury by activating AMPK/mTORC1 signaling pathway.Metab Brain Dis. 2024 Mar;39(3):439-452. doi: 10.1007/s11011-023-01323-2. Epub 2023 Dec 4. Metab Brain Dis. 2024. PMID: 38047978 Review.
-
Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies.Int J Mol Sci. 2023 Sep 9;24(18):13900. doi: 10.3390/ijms241813900. Int J Mol Sci. 2023. PMID: 37762203 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources